Yin, Yihong
Xie, Zhaohong
Chen, Dong
Guo, Hao
Han, Min
Zhu, Zhengyu
Bi, Jianzhong
Funding for this research was provided by:
The Fundamental Research Funds of Shandong University (NO: 2016JC022, NO: 2016JC022)
Article History
Received: 8 September 2021
Accepted: 3 May 2022
First Online: 9 May 2022
Declarations
:
: This process was approved by the ethics committee of First Affiliated Hospital, University of Science and Technology of China (2021KY131) and all volunteers. Informed consent was obtained from all subjects and/or their legal guardian(s). All methods were employed in accordance with the relevant guidelines and regulations.
: Not applicable.
: Author Dong Chen and Hao Guo were employed by the company of Wuhan Ruixing Biotechnology Co. Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. All authors have no personal conflict of interests in this study.